Global Transdermal Patch Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Table of Contents1 Study Coverage
1.1 Transdermal Patch Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Patch Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Market by Application
1.3.1 Global Transdermal Patch Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transdermal Patch Market Size Estimates and Forecasts
2.1.1 Global Transdermal Patch Revenue 2017-2028
2.1.2 Global Transdermal Patch Sales 2017-2028
2.2 Transdermal Patch Market Size by Region: 2022 Versus 2028
2.3 Transdermal Patch Sales by Region (2017-2028)
2.3.1 Global Transdermal Patch Sales by Region: 2017-2022
2.3.2 Global Transdermal Patch Sales Forecast by Region (2023-2028)
2.3.3 Global Transdermal Patch Sales Market Share by Region (2017-2028)
2.4 Transdermal Patch Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Transdermal Patch Revenue by Region: 2017-2022
2.4.2 Global Transdermal Patch Revenue Forecast by Region (2023-2028)
2.4.3 Global Transdermal Patch Revenue Market Share by Region (2017-2028)
3 Global Transdermal Patch by Manufacturers
3.1 Global Top Transdermal Patch Manufacturers by Sales
3.1.1 Global Transdermal Patch Sales by Manufacturer (2017-2022)
3.1.2 Global Transdermal Patch Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Transdermal Patch Manufacturers by Revenue
3.2.1 Global Transdermal Patch Revenue by Manufacturer (2017-2022)
3.2.2 Global Transdermal Patch Revenue Share by Manufacturer (2017-2022)
3.3 Global Transdermal Patch Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Transdermal Patch Manufacturers Covered: Ranking by Revenue
3.4.2 Global Transdermal Patch Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Transdermal Patch Manufacturing Base Distribution, Product Type
3.5.1 Transdermal Patch Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Transdermal Patch Product Type
3.5.3 Date of International Manufacturers Enter into Transdermal Patch Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Hisamitsu Pharmaceutical
4.1.1 Hisamitsu Pharmaceutical Corporation Information
4.1.2 Hisamitsu Pharmaceutical Description, Business Overview
4.1.3 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
4.1.4 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Hisamitsu Pharmaceutical Transdermal Patch Sales by Product in 2021
4.1.6 Hisamitsu Pharmaceutical Transdermal Patch Sales by Application in 2021
4.1.7 Hisamitsu Pharmaceutical Transdermal Patch Sales by Geographic Area in 2021
4.1.8 Hisamitsu Pharmaceutical Recent Developments
4.2 Johnson & Johnson
4.2.1 Johnson & Johnson Corporation Information
4.2.2 Johnson & Johnson Description, Business Overview
4.2.3 Johnson & Johnson Transdermal Patch Products Offered
4.2.4 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Johnson & Johnson Transdermal Patch Sales by Product in 2021
4.2.6 Johnson & Johnson Transdermal Patch Sales by Application in 2021
4.2.7 Johnson & Johnson Transdermal Patch Sales by Geographic Area in 2021
4.2.8 Johnson & Johnson Recent Developments
4.3 Novartis
4.3.1 Novartis Corporation Information
4.3.2 Novartis Description, Business Overview
4.3.3 Novartis Transdermal Patch Products Offered
4.3.4 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Novartis Transdermal Patch Sales by Product in 2021
4.3.6 Novartis Transdermal Patch Sales by Application in 2021
4.3.7 Novartis Transdermal Patch Sales by Geographic Area in 2021
4.3.8 Novartis Recent Developments
4.4 UCB Pharma
4.4.1 UCB Pharma Corporation Information
4.4.2 UCB Pharma Description, Business Overview
4.4.3 UCB Pharma Transdermal Patch Products Offered
4.4.4 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.4.5 UCB Pharma Transdermal Patch Sales by Product in 2021
4.4.6 UCB Pharma Transdermal Patch Sales by Application in 2021
4.4.7 UCB Pharma Transdermal Patch Sales by Geographic Area in 2021
4.4.8 UCB Pharma Recent Developments
4.5 Mylan
4.5.1 Mylan Corporation Information
4.5.2 Mylan Description, Business Overview
4.5.3 Mylan Transdermal Patch Products Offered
4.5.4 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Mylan Transdermal Patch Sales by Product in 2021
4.5.6 Mylan Transdermal Patch Sales by Application in 2021
4.5.7 Mylan Transdermal Patch Sales by Geographic Area in 2021
4.5.8 Mylan Recent Developments
4.6 Teva Pharmaceutical
4.6.1 Teva Pharmaceutical Corporation Information
4.6.2 Teva Pharmaceutical Description, Business Overview
4.6.3 Teva Pharmaceutical Transdermal Patch Products Offered
4.6.4 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Teva Pharmaceutical Transdermal Patch Sales by Product in 2021
4.6.6 Teva Pharmaceutical Transdermal Patch Sales by Application in 2021
4.6.7 Teva Pharmaceutical Transdermal Patch Sales by Geographic Area in 2021
4.6.8 Teva Pharmaceutical Recent Development
4.7 Nitto Denko
4.7.1 Nitto Denko Corporation Information
4.7.2 Nitto Denko Description, Business Overview
4.7.3 Nitto Denko Transdermal Patch Products Offered
4.7.4 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Nitto Denko Transdermal Patch Sales by Product in 2021
4.7.6 Nitto Denko Transdermal Patch Sales by Application in 2021
4.7.7 Nitto Denko Transdermal Patch Sales by Geographic Area in 2021
4.7.8 Nitto Denko Recent Development
4.8 Grünenthal
4.8.1 Grünenthal Corporation Information
4.8.2 Grünenthal Description, Business Overview
4.8.3 Grünenthal Transdermal Patch Products Offered
4.8.4 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Grünenthal Transdermal Patch Sales by Product in 2021
4.8.6 Grünenthal Transdermal Patch Sales by Application in 2021
4.8.7 Grünenthal Transdermal Patch Sales by Geographic Area in 2021
4.8.8 Grünenthal Recent Development
4.9 IBSA Group
4.9.1 IBSA Group Corporation Information
4.9.2 IBSA Group Description, Business Overview
4.9.3 IBSA Group Transdermal Patch Products Offered
4.9.4 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.9.5 IBSA Group Transdermal Patch Sales by Product in 2021
4.9.6 IBSA Group Transdermal Patch Sales by Application in 2021
4.9.7 IBSA Group Transdermal Patch Sales by Geographic Area in 2021
4.9.8 IBSA Group Recent Development
4.10 GSK
4.10.1 GSK Corporation Information
4.10.2 GSK Description, Business Overview
4.10.3 GSK Transdermal Patch Products Offered
4.10.4 GSK Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.10.5 GSK Transdermal Patch Sales by Product in 2021
4.10.6 GSK Transdermal Patch Sales by Application in 2021
4.10.7 GSK Transdermal Patch Sales by Geographic Area in 2021
4.10.8 GSK Recent Development
4.11 Luye Pharma Group
4.11.1 Luye Pharma Group Corporation Information
4.11.2 Luye Pharma Group Description, Business Overview
4.11.3 Luye Pharma Group Transdermal Patch Products Offered
4.11.4 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Luye Pharma Group Transdermal Patch Sales by Product in 2021
4.11.6 Luye Pharma Group Transdermal Patch Sales by Application in 2021
4.11.7 Luye Pharma Group Transdermal Patch Sales by Geographic Area in 2021
4.11.8 Luye Pharma Group Recent Development
4.12 Pfizer
4.12.1 Pfizer Corporation Information
4.12.2 Pfizer Description, Business Overview
4.12.3 Pfizer Transdermal Patch Products Offered
4.12.4 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Pfizer Transdermal Patch Sales by Product in 2021
4.12.6 Pfizer Transdermal Patch Sales by Application in 2021
4.12.7 Pfizer Transdermal Patch Sales by Geographic Area in 2021
4.12.8 Pfizer Recent Development
4.13 Chattem
4.13.1 Chattem Corporation Information
4.13.2 Chattem Description, Business Overview
4.13.3 Chattem Transdermal Patch Products Offered
4.13.4 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Chattem Transdermal Patch Sales by Product in 2021
4.13.6 Chattem Transdermal Patch Sales by Application in 2021
4.13.7 Chattem Transdermal Patch Sales by Geographic Area in 2021
4.13.8 Chattem Recent Development
4.14 Dr Reddy's Laboratories
4.14.1 Dr Reddy's Laboratories Corporation Information
4.14.2 Dr Reddy's Laboratories Description, Business Overview
4.14.3 Dr Reddy's Laboratories Transdermal Patch Products Offered
4.14.4 Dr Reddy's Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.14.5 Dr Reddy's Laboratories Transdermal Patch Sales by Product in 2021
4.14.6 Dr Reddy's Laboratories Transdermal Patch Sales by Application in 2021
4.14.7 Dr Reddy's Laboratories Transdermal Patch Sales by Geographic Area in 2021
4.14.8 Dr Reddy's Laboratories Recent Development
4.15 Bayer
4.15.1 Bayer Corporation Information
4.15.2 Bayer Description, Business Overview
4.15.3 Bayer Transdermal Patch Products Offered
4.15.4 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.15.5 Bayer Transdermal Patch Sales by Product in 2021
4.15.6 Bayer Transdermal Patch Sales by Application in 2021
4.15.7 Bayer Transdermal Patch Sales by Geographic Area in 2021
4.15.8 Bayer Recent Development
4.16 Mundipharma
4.16.1 Mundipharma Corporation Information
4.16.2 Mundipharma Description, Business Overview
4.16.3 Mundipharma Transdermal Patch Products Offered
4.16.4 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.16.5 Mundipharma Transdermal Patch Sales by Product in 2021
4.16.6 Mundipharma Transdermal Patch Sales by Application in 2021
4.16.7 Mundipharma Transdermal Patch Sales by Geographic Area in 2021
4.16.8 Mundipharma Recent Development
4.17 Endo International
4.17.1 Endo International Corporation Information
4.17.2 Endo International Description, Business Overview
4.17.3 Endo International Transdermal Patch Products Offered
4.17.4 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.17.5 Endo International Transdermal Patch Sales by Product in 2021
4.17.6 Endo International Transdermal Patch Sales by Application in 2021
4.17.7 Endo International Transdermal Patch Sales by Geographic Area in 2021
4.17.8 Endo International Recent Development
4.18 Beijing Tide Pharmaceutical
4.18.1 Beijing Tide Pharmaceutical Corporation Information
4.18.2 Beijing Tide Pharmaceutical Description, Business Overview
4.18.3 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
4.18.4 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.18.5 Beijing Tide Pharmaceutical Transdermal Patch Sales by Product in 2021
4.18.6 Beijing Tide Pharmaceutical Transdermal Patch Sales by Application in 2021
4.18.7 Beijing Tide Pharmaceutical Transdermal Patch Sales by Geographic Area in 2021
4.18.8 Beijing Tide Pharmaceutical Recent Development
5 Breakdown Data by Type
5.1 Global Transdermal Patch Sales by Type (2017-2028)
5.1.1 Global Transdermal Patch Sales by Type (2017-2022)
5.1.2 Global Transdermal Patch Sales Forecast by Type (2023-2028)
5.1.3 Global Transdermal Patch Sales Market Share by Type (2017-2028)
5.2 Global Transdermal Patch Revenue Forecast by Type (2017-2028)
5.2.1 Global Transdermal Patch Revenue by Type (2017-2022)
5.2.2 Global Transdermal Patch Revenue Forecast by Type (2023-2028)
5.2.3 Global Transdermal Patch Revenue Market Share by Type (2017-2028)
5.3 Transdermal Patch Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Transdermal Patch Sales by Application (2017-2028)
6.1.1 Global Transdermal Patch Sales by Application (2017-2022)
6.1.2 Global Transdermal Patch Sales Forecast by Application (2023-2028)
6.1.3 Global Transdermal Patch Sales Market Share by Application (2017-2028)
6.2 Global Transdermal Patch Revenue Forecast by Application (2017-2028)
6.2.1 Global Transdermal Patch Revenue by Application (2017-2022)
6.2.2 Global Transdermal Patch Revenue Forecast by Application (2023-2028)
6.2.3 Global Transdermal Patch Revenue Market Share by Application (2017-2028)
6.3 Transdermal Patch Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Transdermal Patch Market Size YoY Growth 2017-2028
7.2 North America Transdermal Patch Market Facts & Figures by Country
7.2.1 North America Transdermal Patch Sales by Country (2017-2028)
7.2.2 North America Transdermal Patch Revenue by Country (2017-2028)
7.3 North America Transdermal Patch Sales by Type
7.4 North America Transdermal Patch Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Patch Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Transdermal Patch Market Facts & Figures by Region
8.2.1 Asia-Pacific Transdermal Patch Sales by Region (2017-2028)
8.2.2 Asia-Pacific Transdermal Patch Revenue by Region (2017-2028)
8.3 Asia-Pacific Transdermal Patch Sales by Type
8.4 Asia-Pacific Transdermal Patch Sales by Application
9 Europe
9.1 Europe Transdermal Patch Market Size YoY Growth 2017-2028
9.2 Europe Transdermal Patch Market Facts & Figures by Country
9.2.1 Europe Transdermal Patch Sales by Country (2017-2028)
9.2.2 Europe Transdermal Patch Revenue by Country (2017-2028)
9.3 Europe Transdermal Patch Sales by Type
9.4 Europe Transdermal Patch Sales by Application
10 Latin America
10.1 Latin America Transdermal Patch Market Size YoY Growth 2017-2028
10.2 Latin America Transdermal Patch Market Facts & Figures by Country
10.2.1 Latin America Transdermal Patch Sales by Country (2017-2028)
10.2.2 Latin America Transdermal Patch Revenue by Country (2017-2028)
10.3 Latin America Transdermal Patch Sales by Type
10.4 Latin America Transdermal Patch Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Transdermal Patch Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Transdermal Patch Market Facts & Figures by Country
11.2.1 Middle East and Africa Transdermal Patch Sales by Country (2017-2028)
11.2.2 Middle East and Africa Transdermal Patch Revenue by Country (2017-2028)
11.3 Middle East and Africa Transdermal Patch Sales by Type
11.4 Middle East and Africa Transdermal Patch Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Transdermal Patch Supply Chain Analysis
12.2 Transdermal Patch Key Raw Materials and Upstream Suppliers
12.3 Transdermal Patch Clients Analysis
12.4 Transdermal Patch Sales Channel and Sales Model Analysis
12.4.1 Transdermal Patch Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Transdermal Patch Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Transdermal Patch Distributors
13 Market Dynamics
13.1 Transdermal Patch Industry Trends
13.2 Transdermal Patch Market Drivers
13.3 Transdermal Patch Market Challenges
13.4 Transdermal Patch Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesTable 1. Global Transdermal Patch Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Methyl Salicylate-based Patch
Table 3. Major Manufacturers of Rivastigmine Transdermal Patch
Table 4. Major Manufacturers of Fentanyl Transdermal Patch
Table 5. Major Manufacturers of Lidocaine Patch
Table 6. Major Manufacturers of Diclofenac Patch
Table 7. Major Manufacturers of Nicotine Transdermal Patch
Table 8. Major Manufacturers of Others
Table 9. Global Transdermal Patch Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Transdermal Patch Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 11. Global Transdermal Patch Sales by Region (2017-2022) & (M Pcs)
Table 12. Global Transdermal Patch Sales Forecast by Region (2023-2028) & (M Pcs)
Table 13. Global Transdermal Patch Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Transdermal Patch Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Transdermal Patch Sales by Manufacturer (2017-2022) & (M Pcs)
Table 16. Global Transdermal Patch Sales Share by Manufacturer (2017-2022)
Table 17. Transdermal Patch Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 18. Transdermal Patch Revenue Share by Manufacturer (2017-2022)
Table 19. Key Manufacturers Transdermal Patch Price (2017-2022) & (USD/Pc)
Table 20. Ranking of Global Top Transdermal Patch Manufacturers by Revenue (US$ Million) in 2021
Table 21. Global Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 22. Global Transdermal Patch by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Patch as of 2021)
Table 23. Transdermal Patch Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Transdermal Patch Product Type
Table 25. Date of International Manufacturers Enter into Transdermal Patch Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Hisamitsu Pharmaceutical Corporation Information
Table 28. Hisamitsu Pharmaceutical Description and Business Overview
Table 29. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 30. Hisamitsu Pharmaceutical Transdermal Patch Product
Table 31. Hisamitsu Pharmaceutical Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 32. Hisamitsu Pharmaceutical Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 33. Hisamitsu Pharmaceutical Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 34. Hisamitsu Pharmaceutical Recent Development
Table 35. Johnson & Johnson Corporation Information
Table 36. Johnson & Johnson Description and Business Overview
Table 37. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 38. Johnson & Johnson Transdermal Patch Product
Table 39. Johnson & Johnson Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 40. Johnson & Johnson Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 41. Johnson & Johnson Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 42. Johnson & Johnson Recent Development
Table 43. Novartis Corporation Information
Table 44. Novartis Description and Business Overview
Table 45. Novartis Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 46. Novartis Transdermal Patch Product
Table 47. Novartis Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 48. Novartis Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 49. Novartis Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 50. Novartis Recent Development
Table 51. UCB Pharma Corporation Information
Table 52. UCB Pharma Description and Business Overview
Table 53. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 54. UCB Pharma Transdermal Patch Product
Table 55. UCB Pharma Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 56. UCB Pharma Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 57. UCB Pharma Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 58. UCB Pharma Recent Development
Table 59. Mylan Corporation Information
Table 60. Mylan Description and Business Overview
Table 61. Mylan Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 62. Mylan Transdermal Patch Product
Table 63. Mylan Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 64. Mylan Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 65. Mylan Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 66. Mylan Recent Development
Table 67. Teva Pharmaceutical Corporation Information
Table 68. Teva Pharmaceutical Description and Business Overview
Table 69. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 70. Teva Pharmaceutical Transdermal Patch Product
Table 71. Teva Pharmaceutical Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 72. Teva Pharmaceutical Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 73. Teva Pharmaceutical Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 74. Nitto Denko Corporation Information
Table 75. Nitto Denko Description and Business Overview
Table 76. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 77. Nitto Denko Transdermal Patch Product
Table 78. Nitto Denko Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 79. Nitto Denko Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 80. Nitto Denko Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 81. Grünenthal Corporation Information
Table 82. Grünenthal Description and Business Overview
Table 83. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 84. Grünenthal Transdermal Patch Product
Table 85. Grünenthal Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 86. Grünenthal Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 87. Grünenthal Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 88. IBSA Group Corporation Information
Table 89. IBSA Group Description and Business Overview
Table 90. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 91. IBSA Group Transdermal Patch Product
Table 92. IBSA Group Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 93. IBSA Group Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 94. IBSA Group Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 95. GSK Corporation Information
Table 96. GSK Description and Business Overview
Table 97. GSK Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 98. GSK Transdermal Patch Product
Table 99. GSK Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 100. GSK Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 101. GSK Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 102. Luye Pharma Group Corporation Information
Table 103. Luye Pharma Group Description and Business Overview
Table 104. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 105. Luye Pharma Group Transdermal Patch Product
Table 106. Luye Pharma Group Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 107. Luye Pharma Group Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 108. Luye Pharma Group Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 109. Pfizer Corporation Information
Table 110. Pfizer Description and Business Overview
Table 111. Pfizer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 112. Pfizer Transdermal Patch Product
Table 113. Pfizer Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 114. Pfizer Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 115. Pfizer Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 116. Chattem Corporation Information
Table 117. Chattem Description and Business Overview
Table 118. Chattem Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 119. Chattem Transdermal Patch Product
Table 120. Chattem Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 121. Chattem Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 122. Chattem Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 123. Dr Reddy's Laboratories Corporation Information
Table 124. Dr Reddy's Laboratories Description and Business Overview
Table 125. Dr Reddy's Laboratories Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 126. Dr Reddy's Laboratories Transdermal Patch Product
Table 127. Dr Reddy's Laboratories Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 128. Dr Reddy's Laboratories Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 129. Dr Reddy's Laboratories Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 130. Bayer Corporation Information
Table 131. Bayer Description and Business Overview
Table 132. Bayer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 133. Bayer Transdermal Patch Product
Table 134. Bayer Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 135. Bayer Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 136. Bayer Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 137. Mundipharma Corporation Information
Table 138. Mundipharma Description and Business Overview
Table 139. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 140. Mundipharma Transdermal Patch Product
Table 141. Mundipharma Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 142. Mundipharma Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 143. Mundipharma Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 144. Endo International Corporation Information
Table 145. Endo International Description and Business Overview
Table 146. Endo International Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 147. Endo International Transdermal Patch Product
Table 148. Endo International Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 149. Endo International Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 150. Endo International Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 151. Beijing Tide Pharmaceutical Corporation Information
Table 152. Beijing Tide Pharmaceutical Description and Business Overview
Table 153. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 154. Beijing Tide Pharmaceutical Transdermal Patch Product
Table 155. Beijing Tide Pharmaceutical Transdermal Patch Sales Proportion of Transdermal Patch by Product in 2021
Table 156. Beijing Tide Pharmaceutical Transdermal Patch Sales Proportion of Transdermal Patch by Application in 2021
Table 157. Beijing Tide Pharmaceutical Transdermal Patch Sales Proportion of Transdermal Patch by Geographic Area in 2021
Table 158. Global Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
Table 159. Global Transdermal Patch Sales Forecast by Type (2023-2028) & (M Pcs)
Table 160. Global Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
Table 161. Global Transdermal Patch Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 162. Global Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
Table 163. Global Transdermal Patch Sales Forecast by Application (2023-2028) & (M Pcs)
Table 164. Global Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
Table 165. Global Transdermal Patch Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 166. North America Transdermal Patch Sales by Country (2017-2022) & (M Pcs)
Table 167. North America Transdermal Patch Sales by Country (2023-2028) & (M Pcs)
Table 168. North America Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)
Table 169. North America Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)
Table 170. North America Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
Table 171. North America Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
Table 172. Asia-Pacific Transdermal Patch Sales by Region (2017-2022) & (M Pcs)
Table 173. Asia-Pacific Transdermal Patch Sales by Region (2023-2028) & (M Pcs)